{"id":"https://openalex.org/W2106091936","doi":null,"title":"5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.","display_name":"5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.","publication_year":1996,"publication_date":"1996-03-15","ids":{"openalex":"https://openalex.org/W2106091936","mag":"2106091936","pmid":"https://pubmed.ncbi.nlm.nih.gov/8640798"},"language":"en","primary_location":{"id":"pmid:8640798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8640798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003562375","display_name":"Ganesan Vaidyanathan","orcid":"https://orcid.org/0000-0003-3041-8275","observed_orcids":["https://orcid.org/0000-0003-3041-8275"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Vaidyanathan","raw_affiliation_strings":["Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005283403","display_name":"Roy H. Larsen","orcid":"https://orcid.org/0000-0002-9295-7656","observed_orcids":["https://orcid.org/0000-0002-9295-7656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R H Larsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5045964365","display_name":"Michael R. Zalutsky","orcid":"https://orcid.org/0000-0002-5456-0324","observed_orcids":["https://orcid.org/0000-0002-5456-0324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M R Zalutsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8768,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.95174037,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"56","issue":"6","first_page":"1204","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/astatine-211","display_name":"astatine-211","score":0.9290000200271606},{"id":"https://openalex.org/keywords/alpha-emitting-radiopharmaceuticals","display_name":"alpha-emitting radiopharmaceuticals","score":0.8339999914169312},{"id":"https://openalex.org/keywords/endoradiotherapy","display_name":"endoradiotherapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dna-incorporation","display_name":"DNA incorporation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/iodine-125","display_name":"iodine-125","score":0.7099999785423279},{"id":"https://openalex.org/keywords/iodine-123","display_name":"iodine-123","score":0.9980000257492065},{"id":"https://openalex.org/keywords/5-iododeoxyuridine","display_name":"5-iodo-2'-deoxyuridine","score":0.9259999990463257},{"id":"https://openalex.org/keywords/glioma-cells","display_name":"glioma cells","score":0.527999997138977},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.675000011920929},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.6940000057220459},{"id":"https://openalex.org/keywords/radiosynthesis","display_name":"radiotracer synthesis","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C2777111502","wikidata":"https://www.wikidata.org/wiki/Q419140","display_name":"Deoxyuridine","level":3,"score":0.8540424108505249},{"id":"https://openalex.org/C2777108182","wikidata":"https://www.wikidata.org/wiki/Q422464","display_name":"Thymidine","level":3,"score":0.62269526720047},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.58929842710495},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.576069712638855},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5424090623855591},{"id":"https://openalex.org/C2781088732","wikidata":"https://www.wikidata.org/wiki/Q409765","display_name":"Idoxuridine","level":3,"score":0.5280077457427979},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5134066343307495},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.5118655562400818},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4376770257949829},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.43082308769226074},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4186314642429352},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31725502014160156},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.166011244058609},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10092154145240784},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08269202709197998},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007065","descriptor_name":"Idoxuridine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007065","descriptor_name":"Idoxuridine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D007065","descriptor_name":"Idoxuridine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007065","descriptor_name":"Idoxuridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007065","descriptor_name":"Idoxuridine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018499","descriptor_name":"Linear Energy Transfer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8640798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8640798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2106091936","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8640798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5487233072","display_name":"SRC on Primary Tumors of the CNS","funder_award_id":"5p50ns020023-30","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1552305609","https://openalex.org/W1602336352","https://openalex.org/W1892689207","https://openalex.org/W1969411349","https://openalex.org/W2007382653","https://openalex.org/W2028679141","https://openalex.org/W2034347966","https://openalex.org/W2055466144","https://openalex.org/W2071331821","https://openalex.org/W2085953840","https://openalex.org/W2152982472","https://openalex.org/W2563434236"],"related_works":["https://openalex.org/W2158524491","https://openalex.org/W2036230815","https://openalex.org/W2148138196","https://openalex.org/W58916358","https://openalex.org/W2266613100","https://openalex.org/W1963646933","https://openalex.org/W2043639661","https://openalex.org/W59357068","https://openalex.org/W2313842426","https://openalex.org/W2156779149"],"abstract_inverted_index":{"When":[0],"labeled":[1,54],"with":[2,43,55,113,149],"the":[3,12,60,69,81,89,125],"subcellular":[4],"range":[5,45],"Auger":[6],"electron":[7],"emitters":[8],"125I":[9],"and":[10,124],"123I,":[11],"thymidine":[13],"analogue":[14,53],"5-iodo-2'deoxyuridine":[15],"(IUdR)":[16],"is":[17],"highly":[18],"cytotoxic":[19],"but":[20,42],"only":[21],"to":[22,29,103,153],"cells":[23],"going":[24],"through":[25],"S-phase":[26],"during":[27],"exposure":[28],"these":[30],"radiopharmaceuticals.":[31],"Since":[32],"211":[33],"At":[34],"emits":[35],"alpha-particles":[36],"of":[37,46,62,71,83,118,127,130],"high":[38,143],"linear":[39,108],"energy":[40],"transfer,":[41],"a":[44,47,107,136,142,150],"few":[48],"cell":[49,92,111],"diameters,":[50],"an":[51,116],"IUdR":[52],"211At":[56,157],"could":[57],"markedly":[58],"improve":[59],"homogeneity":[61],"tumor":[63],"dose":[64],"deposition.":[65],"Herein":[66],"we":[67],"describe":[68],"synthesis":[70],"5-[211":[72],"At]astato-2'-deoxyuridine":[73],"([211":[74],"At]AUdR)":[75],"in":[76,110],"85-90%":[77],"radiochemical":[78],"yield":[79],"via":[80],"astatodestannylation":[82],"5-(trimethylstannyl)-2'-deoxyuridine.":[84],"In":[85,135],"vitro":[86],"studies":[87],"using":[88],"human":[90],"glioma":[91],"line":[93],"D-247":[94,146],"MG":[95,147],"demonstrated":[96],"that":[97],"[211":[98,139],"At]AUdR":[99,140],"was":[100],"virtually":[101],"identical":[102],"[131I]IUdr;":[104],"both":[105],"exhibited":[106,141],"increase":[109],"uptake":[112,119],"activity":[114,132],"concentration,":[115],"inhibition":[117],"by":[120],"10":[121],"micrometers":[122],"IUdR,":[123],"incorporation":[126],"about":[128],"50%":[129],"cell-bound":[131],"into":[133],"DNA.":[134],"clonogenic":[137],"assay,":[138],"cytotoxicity":[144],"for":[145],"cells,":[148],"D(0)":[151],"equivalent":[152],"less":[154],"than":[155],"3":[156],"atoms/cell.":[158]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}